AgomAb Therapeutics’ (NASDAQ:AGMB – Get Free Report) lock-up period is set to expire on Wednesday, August 5th. AgomAb Therapeutics had issued 12,500,000 shares in its IPO on February 6th. The total size of the offering was $200,000,000 based on an initial share price of $16.00. After the end of the company’s lock-up period, major shareholders […]